help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hollingsworth, H. C.
Right arrow Articles by Merino, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hollingsworth, H. C.
Right arrow Articles by Merino, M. J.

American Journal of Pathology, Vol 147, 33-41, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Tumor angiogenesis in advanced stage ovarian carcinoma

HC Hollingsworth, EC Kohn, SM Steinberg, ML Rothenberg and MJ Merino
Laboratory of Pathology and Biostatistics, National Cancer Institute, Bethesda, Maryland 20892, USA.

Tumor angiogenesis has been found to have prognostic significance in many tumor types for predicting an increased risk of metastasis. We assessed tumor vascularity in 43 cases of advanced stage (International Federation of Gynecologists and Obstetricians stages III and IV) ovarian cancer by using the highly specific endothelial cell marker CD34. Microvessel counts and stage were associated with disease-free survival and with overall survival by Kaplan-Meier analysis. The plots show that higher stage, higher average vessel count at 200x (200x avg) and 400x (400x avg) magnification and highest vessel count at 400x (400x high) magnification confer a worse prognosis for disease-free survival. Average vessel count of less than 16 (400x avg, P2 = 0.01) and less than 45 (200x avg, P2 = 0.026) suggested a better survival. Similarly, a high vessel count of less than 20 (400x high, P2 = 0.019) conferred a better survival as well. The plots suggest that higher stage, higher average vessel count at 200x and 400x, and highest vessel count at 200x and 400x show a trend to worse overall survival as well. With the Cox proportional hazards model, stage was the best predictor of overall survival, however, the average microvessel count at 400x was found to be the best predictor of disease-free survival. These results suggest that analysis of neovascularization in advanced stage ovarian cancer may be a useful prognostic factor.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
T. J. Duncan, A. Al-Attar, P. Rolland, I. V. Scott, S. Deen, D. T.Y. Liu, I. Spendlove, and L. G. Durrant
Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
Clin. Cancer Res., May 15, 2008; 14(10): 3030 - 3035.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. A. Burger, M. W. Sill, B. J. Monk, B. E. Greer, and J. I. Sorosky
Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
J. Clin. Oncol., November 20, 2007; 25(33): 5165 - 5171.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. A. Cannistra, U. A. Matulonis, R. T. Penson, J. Hambleton, J. Dupont, H. Mackey, J. Douglas, R. A. Burger, D. Armstrong, R. Wenham, et al.
Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer
J. Clin. Oncol., November 20, 2007; 25(33): 5180 - 5186.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. A. Burger
Experience With Bevacizumab in the Management of Epithelial Ovarian Cancer
J. Clin. Oncol., July 10, 2007; 25(20): 2902 - 2908.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. M. Robinson-Smith, I. Isaacsohn, C. A. Mercer, M. Zhou, N. Van Rooijen, N. Husseinzadeh, M. M. McFarland-Mancini, and A. F. Drew
Macrophages Mediate Inflammation-Enhanced Metastasis of Ovarian Tumors in Mice
Cancer Res., June 15, 2007; 67(12): 5708 - 5716.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Hara, S. Samuel, J. Liu, D. Rosen, R. R. Langley, and H. Naora
A Homeobox Gene Related to Drosophila Distal-Less Promotes Ovarian Tumorigenicity by Inducing Expression of Vascular Endothelial Growth Factor and Fibroblast Growth Factor-2
Am. J. Pathol., May 1, 2007; 170(5): 1594 - 1606.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
Y. Yao, Y. Pan, J. Chen, X. Sun, Y. Qiu, and Y. Ding
Endoglin (CD105) Expression in Angiogenesis of Primary Hepatocellular Carcinomas: Analysis using Tissue Microarrays and Comparisons with CD34 and VEGF
Ann. Clin. Lab. Sci., January 1, 2007; 37(1): 39 - 48.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
O. Lucidarme, Y. Kono, J. Corbeil, S.-H. Choi, J.-L. Golmard, J. Varner, and R. F. Mattrey
Angiogenesis: Noninvasive Quantitative Assessment with Contrast-enhanced Functional US in Murine Model.
Radiology, June 1, 2006; 239(3): 730 - 739.
[Abstract] [Full Text] [PDF]

Home page
 Integr Cancer TherHome page
D. R. Yance Jr and S. M. Sagar
Targeting angiogenesis with integrative cancer therapies.
Integr Cancer Ther, March 1, 2006; 5(1): 9 - 29.
[Abstract] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
T. Szoke, K. Kayser, J.-D. Baumhakel, I. Trojan, J. Furak, L. Tiszlavicz, J. Eller, and K. Boda
Prognostic significance of microvascularization in cases of operated lung cancer
Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1106 - 1111.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Suganuma, K. Ino, K. Shibata, H. Kajiyama, T. Nagasaka, S. Mizutani, and F. Kikkawa
Functional Expression of the Angiotensin II Type1 Receptor in Human Ovarian Carcinoma Cells and Its Blockade Therapy Resulting in Suppression of Tumor Invasion, Angiogenesis, and Peritoneal Dissemination
Clin. Cancer Res., April 1, 2005; 11(7): 2686 - 2694.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. K. Chan, V. Loizzi, A. Magistris, F. Lin, J. Rutgers, K. Osann, P. J. DiSaia, and M. L. Berman
Differences in Prognostic Molecular Markers between Women Over and Under 45 Years of Age with Advanced Ovarian Cancer
Clin. Cancer Res., December 15, 2004; 10(24): 8538 - 8543.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Uehara, M. Miyamoto, K. Kato, Y. Ebihara, H. Kaneko, H. Hashimoto, Y. Murakami, R. Hase, R. Takahashi, S. Mega, et al.
Expression of Pigment Epithelium-Derived Factor Decreases Liver Metastasis and Correlates with Favorable Prognosis for Patients with Ductal Pancreatic Adenocarcinoma
Cancer Res., May 15, 2004; 64(10): 3533 - 3537.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Garofalo, E. Naumova, L. Manenti, C. Ghilardi, G. Ghisleni, M. Caniatti, T. Colombo, J. M. Cherrington, E. Scanziani, M. I. Nicoletti, et al.
The Combination of the Tyrosine Kinase Receptor Inhibitor SU6668 with Paclitaxel Affects Ascites Formation and Tumor Spread in Ovarian Carcinoma Xenografts Growing Orthotopically
Clin. Cancer Res., August 1, 2003; 9(9): 3476 - 3485.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M A Ghanem, G J van Steenbrugge, M K Sudaryo, R B Mathoera, J M Nijman, and T. H van der Kwast
Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma
J. Clin. Pathol., February 1, 2003; 56(2): 107 - 113.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
E S Bamberger and C W Perrett
Angiogenesis in epithelian ovarian cancer
Mol. Pathol., December 1, 2002; 55(6): 348 - 359.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. A. Liotta and E. C. Kohn
Stromal Therapy: The Next Step in Ovarian Cancer Treatment
J Natl Cancer Inst, August 7, 2002; 94(15): 1113 - 1114.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. Huang, M. Van Arsdall, S. Tedjarati, M. McCarty, W. Wu, R. Langley, and I. J. Fidler
Contributions of Stromal Metalloproteinase-9 to Angiogenesis and Growth of Human Ovarian Carcinoma in Mice
J Natl Cancer Inst, August 7, 2002; 94(15): 1134 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. C. A. Duyndam, M. C. G. W. Hilhorst, H. M. M. Schluper, H. M. W. Verheul, P. J. van Diest, G. Kraal, H. M. Pinedo, and E. Boven
Vascular Endothelial Growth Factor-165 Overexpression Stimulates Angiogenesis and Induces Cyst Formation and Macrophage Infiltration in Human Ovarian Cancer Xenografts
Am. J. Pathol., February 1, 2002; 160(2): 537 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
A. K. Sood, M. S. Fletcher, and M. J. C. Hendrix
The Embryonic-Like Properties of Aggressive Human Tumor Cells
Reproductive Sciences, January 1, 2002; 9(1): 2 - 9.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
P. J. Mahasreshti, J. G. Navarro, M. Kataram, M. H. Wang, D. Carey, G. P. Siegal, M. N. Barnes, D. M. Nettelbeck, R. D. Alvarez, A. Hemminki, et al.
Adenovirus-mediated Soluble FLT-1 Gene Therapy for Ovarian Carcinoma
Clin. Cancer Res., July 1, 2001; 7(7): 2057 - 2066.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Birner, M. Schindl, A. Obermair, G. Breitenecker, and G. Oberhuber
Expression of Hypoxia-inducible Factor 1{{alpha}} in Epithelial Ovarian Tumors: Its Impact on Prognosis and on Response to Chemotherapy
Clin. Cancer Res., June 1, 2001; 7(6): 1661 - 1668.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
A. K. Sood, E. A. Seftor, M. S. Fletcher, L. M. G. Gardner, P. M. Heidger, R. E. Buller, R. E. B. Seftor, and M. J. C. Hendrix
Molecular Determinants of Ovarian Cancer Plasticity
Am. J. Pathol., April 1, 2001; 158(4): 1279 - 1288.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
H. Kuniyasu, W. Yasui, H. Shinohara, S. Yano, L. M. Ellis, M. R. Wilson, C. D. Bucana, T. Rikita, E. Tahara, and I. J. Fidler
Induction of Angiogenesis by Hyperplastic Colonic Mucosa Adjacent to Colon Cancer
Am. J. Pathol., November 1, 2000; 157(5): 1523 - 1535.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Salani, V. Di Castro, M. R. Nicotra, L. Rosano, R. Tecce, A. Venuti, P. G. Natali, and A. Bagnato
Role of Endothelin-1 in Neovascularization of Ovarian Carcinoma
Am. J. Pathol., November 1, 2000; 157(5): 1537 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Aguayo, H. Kantarjian, T. Manshouri, C. Gidel, E. Estey, D. Thomas, C. Koller, Z. Estrov, S. O'Brien, M. Keating, et al.
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
Blood, September 15, 2000; 96(6): 2240 - 2245.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Kuniyasu, P. Troncoso, D. Johnston, C. D. Bucana, E. Tahara, I. J. Fidler, and C. A. Pettaway
Relative Expression of Type IV Collagenase, E-cadherin, and Vascular Endothelial Growth Factor/Vascular Permeability Factor in Prostatectomy Specimens Distinguishes Organ-confined from Pathologically Advanced Prostate Cancers
Clin. Cancer Res., June 1, 2000; 6(6): 2295 - 2308.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
T. Hasebe, S. Sasaki, S. Imoto, and A. Ochiai
Proliferative Activity of Intratumoral Fibroblasts Is Closely Correlated with Lymph Node and Distant Organ Metastases of Invasive Ductal Carcinoma of the Breast
Am. J. Pathol., May 1, 2000; 156(5): 1701 - 1710.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
O. ABULAFIA, J. E. RUIZ, K. HOLCOMB, T. M. DIMAIO, Y.-C. LEE, and D. M. SHERER
Angiogenesis in Early-Invasive and Low-Malignant-Potential Epithelial Ovarian Carcinoma
Obstet. Gynecol., April 1, 2000; 95(4): 548 - 552.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Folberg, M. J. C. Hendrix, and A. J. Maniotis
Vasculogenic Mimicry and Tumor Angiogenesis
Am. J. Pathol., February 1, 2000; 156(2): 361 - 381.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. Canete, S. Navarro, J. Bermudez, A. Pellin, V. Castel, and A. Llombart-Bosch
Angiogenesis in Neuroblastoma: Relationship to Survival and Other Prognostic Factors in a Cohort of Neuroblastoma Patients
J. Clin. Oncol., January 5, 2000; 18(1): 27 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Hazelton, R. F. Nicosia, and S. V. Nicosia
Vascular Endothelial Growth Factor Levels in Ovarian Cyst Fluid Correlate with Malignancy
Clin. Cancer Res., April 1, 1999; 5(4): 823 - 829.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. A. Alvarez, H. R. Krigman, R. S. Whitaker, R. K. Dodge, and G. C. Rodriguez
The Prognostic Significance of Angiogenesis in Epithelial Ovarian Carcinoma
Clin. Cancer Res., March 1, 1999; 5(3): 587 - 591.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. P. Stevenson, W. P. Collins, F. Farzaneh, K. Hata, and K. Miyazaki
Thymidine Phosphorylase Activity and Prodrug Effects in a Three-Dimensional Model of Angiogenesis : Implications for the Treatment of Ovarian Cancer
Am. J. Pathol., November 1, 1998; 153(5): 1573 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Mesiano, N. Ferrara, and R. B. Jaffe
Role of Vascular Endothelial Growth Factor in Ovarian Cancer : Inhibition of Ascites Formation by Immunoneutralization
Am. J. Pathol., October 1, 1998; 153(4): 1249 - 1256.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
K. Matsuyama, Y. Chiba, M. Sasaki, H. Tanaka, R. Muraoka, and N. Tanigawa
Tumor Angiogenesis as a Prognostic Marker in Operable Non-Small Cell Lung Cancer
Ann. Thorac. Surg., May 1, 1998; 65(5): 1405 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. A. Soslow, L. Ying, and N. K. Altorki
EXPRESSION OF ACIDIC FIBROBLAST GROWTH FACTOR IN BARRETT'S ESOPHAGUS AND ASSOCIATED ESOPHAGEAL ADENOCARCINOMA
J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 838 - 843.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.